C.M. Bidwell & Associates’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-136
Closed -$4.75K – 481
2025
Q1
$4.75K Buy
136
+43
+46% +$1.71K ﹤0.01% 316
2024
Q4
$4.14K Hold
93
– – ﹤0.01% 357
2024
Q3
$4.05K Buy
+93
New +$3.5K ﹤0.01% 370
2022
Q1
– Sell
-499
Closed -$90K – 587
2021
Q4
$90K Sell
499
-8
-2% -$1.39K 0.06% 247
2021
Q3
$75K Buy
+507
New +$77.7K 0.05% 258
2020
Q1
– Sell
-865
Closed -$71K – 428
2019
Q4
$71K Buy
865
+10
+1% +$767 0.06% 188
2019
Q3
$62K Sell
855
-520
-38% -$38.2K 0.06% 237
2019
Q2
$118K Buy
1,375
+855
+164% +$69.5K 0.12% 160
2019
Q1
$42K Buy
+520
New +$38.9K 0.04% 258
2013
Q4
– Sell
-7,440
Closed -$176K – 243
2013
Q3
$176K Sell
7,440
-415
-5% -$9.25K 0.05% 169
2013
Q2
$161K Buy
+7,855
New +$145K 0.05% 162

Other funds holding OMCL

C.M. Bidwell & Associates's OMCL Position: Q2 2025 in Review

C.M. Bidwell & Associates sold out of Omnicell (OMCL) in Q2 2025, closing a stake of 136 shares — an estimated $4.75K sold.

C.M. Bidwell & Associates first reported a position in OMCL in Q2 2013 and held it in 11 quarters. The position peaked at $176K in Q3 2013. 247 funds tracked by Wall St. Rank hold OMCL as of Q2 2025.

  • C.M. Bidwell & Associates reported no remaining Omnicell position as of Q2 2025 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 136 Omnicell shares in Q2 2025, an estimated $4.75K.
  • C.M. Bidwell & Associates first reported a position in Omnicell in Q2 2013 and held it in 11 quarters.
  • C.M. Bidwell & Associates's Omnicell position peaked at $176K in Q3 2013.
  • 247 funds tracked by Wall St. Rank held Omnicell as of Q2 2025.

Based on C.M. Bidwell & Associates's 13F filing for Q2 2025, filed 14 Aug 2025.